|

Tumor Infiltrating Lymphocyte Clinical Trials

2 actively recruiting trials

Pipeline

Early 1: 2

Top Sponsors

  • Shanghai Juncell Therapeutics2

Indications

  • Tumor Infiltrating Lymphocyte2
  • Effects of Immunotherapy2
  • Treatment Side Effects2
  • Cancer2
  • Advanced Liver Cancers1

Other2 trials

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
Early 1
A Study of GC101 TIL in Advanced Melanoma (10hospital)
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.